Evidence map›Paper›PMID 42385157›Full record

ArticleStatistics in medicine2026

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Lingxiao Wang, Hormuzd A Katki, Anil K Chaturvedi, Li C Cheung

Abstract read
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lingxiao WangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland, USA.ORCID https://orcid.org/0000-0002-3463-615X
Hormuzd A KatkiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland, USA.
Anil K ChaturvediDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland, USA.
Li C CheungDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, Maryland, USA.ORCID https://orcid.org/0000-0003-1625-4331

Funding

NIH Intramural Research Program
6 · The paper itself

Abstract

The current bedrock of precision prevention is selecting high-risk individuals for screening or other prevention services under the assumption that those at highest risk would have the highest benefit from prevention services. However, this may not hold when disease risk and competing mortality are highly correlated. In such cases, risk-based prevention may preferentially select older individuals with multiple comorbidities who would have substantially reduced life-years gainable from the service and increased risks of harm from any resulting surgical procedures. For such prevention services, we propose a benefit-based selection strategy in which individuals are selected according to their expected gain in life-years (i.e., difference in mean survival time with and without the prevention service). We estimate the expected gain in life-years for individuals in a target screening population by combining data from a randomized trial, which may not be population-representative, and data from a population-representative survey that has larger sample size, more covariates, and longer follow-up time to evaluate mortality than the trial. We derive the Taylor-linearized variances for the estimated expected gain in life-years that take into account the randomness due to both trial and survey sample. We show that benefit-based selection of ever-smokers for lung-cancer screening can identify individuals with more favorable benefit-harm trade-offs compared to risk-based selection. Using simulation studies, we examine the conditions in which one strategy may be preferable over the other.

Indexed as

Life ExpectancyPrecision MedicinePreventive Health ServicesAgedComputer SimulationFemaleHumansLung NeoplasmsMaleMass ScreeningMiddle AgedModels, StatisticalRandomized Controlled Trials as TopicRisk AssessmentSurvival Analysisabsolute risk predictioncompeting riskspopulation representative risk modelingprecision cancer screeningrestricted mean survival timesurvival analysis

Identifiers

PMID42385157
PMCPMC13349529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.